Medicine and Dentistry
Abdominal Hysterectomy
5%
Adolescent
10%
Adverse Event
29%
Alcohol Liver Cirrhosis
6%
Alcohol Liver Disease
14%
All Cause Mortality
8%
Androgen
5%
Antioxidant
8%
Atrial Fibrillation
6%
Brain Injury
11%
Cardiovascular System
5%
Clinical Research
8%
Clinical Trial
20%
Coronary Artery Bypass Graft
5%
Coronary Artery Bypass Surgery
5%
COVID-19
7%
Disease
13%
Exercise
5%
Fetus Growth
5%
Glycon
8%
Heart Rehabilitation
10%
Hypoxia
6%
Intensive Care
6%
Intention-to-Treat Analysis
6%
Ischemic Heart Disease
11%
Liver Cirrhosis
11%
Liver Disease
7%
Major Depressive Episode
11%
Maturity Onset Diabetes of the Young
9%
Meta-Analysis
52%
near Infrared Spectroscopy
10%
Obesity
5%
Observational Study
6%
Oximetry
8%
Patient with Type 2 Diabetes
7%
Placebo
41%
Prevalence
8%
Primary Biliary Cirrhosis
8%
Quality of Life
14%
Randomized Clinical Trial
100%
Randomized Controlled Trial
14%
Rehabilitation Engineering
6%
Sequential Analysis
64%
Symptom
8%
Systematic Review
50%
Systematic Review with Meta-Analysis
41%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
45%
Alcohol Liver Cirrhosis
11%
Alcohol Liver Disease
19%
All Cause Mortality
26%
Alpha Interferon
6%
Antivirus Agent
5%
Attention Deficit Disorder
10%
Beta Adrenergic Receptor Blocking Agent
5%
Cardiovascular Mortality
7%
Chronic Hepatitis B
13%
Chronic Hepatitis C
18%
Clarithromycin
10%
Clinical Research
8%
Clinical Trial
16%
Combination Therapy
5%
Coronary Artery Disease
10%
Coronavirinae
7%
Dexamethasone
5%
Disease
19%
Ethanol
6%
Glucocorticoid
10%
Heart Failure
5%
Heart Infarction
12%
Hepatitis B
6%
Hepatitis C
7%
Infection
5%
Interferon
9%
Ischemic Heart Disease
19%
Liver Cirrhosis
9%
Liver Disease
10%
Liver Fibrosis
5%
Major Depression
7%
Metformin
8%
Methylphenidate
10%
Monotherapy
7%
Non Insulin Dependent Diabetes Mellitus
10%
Placebo
59%
Prevalence
7%
Primary Biliary Cirrhosis
5%
Randomized Clinical Trial
80%
Randomized Controlled Trial
11%
Ribavirin
13%
Sepsis
5%
Symptom
5%
Nursing and Health Professions
Adverse Event
12%
Alcohol Liver Cirrhosis
6%
Alcohol Liver Disease
8%
Antioxidant
7%
Clinical Practice
5%
Confidence Interval
16%
Disease
6%
Heart Rehabilitation
8%
Intensive Care
5%
Ischemic Heart Disease
7%
Major Depression
9%
Meta Analysis
30%
Metformin
7%
near Infrared Spectroscopy
8%
Non Insulin Dependent Diabetes Mellitus
5%
Patient with Type 2 Diabetes
6%
Placebo
16%
Practice Guideline
9%
Prevalence
5%
Primary Biliary Cirrhosis
8%
Quality of Life
7%
Random Error
7%
Randomization
5%
Rehabilitation Engineering
6%
Sequential Analysis
26%
Symptom
5%
Systematic Review
26%
Systematic Review with Meta-Analysis
17%
